Covered recipient · General Payments record
MICHEAL S MCGREW
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$2,916.87
- Reported across 122 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $494.32 | 26 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $107.47 | 5 |
| ABBVIE INC. | $96.43 | 4 |
| Acerta Pharma LLC | $55.56 | 4 |
| GlaxoSmithKline, LLC. | $50.49 | 3 |
| Janssen Pharmaceuticals, Inc | $46.73 | 2 |
| Novo Nordisk AS | $46.12 | 3 |
| Lilly USA, LLC | $38.50 | 2 |
| Organon LLC | $36.93 | 2 |
| PFIZER INC. | $16.09 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (26)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $25.36 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105003453 | CMS |
| ABBVIE INC. | $27.71 | 03/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105003455 | CMS |
| ABBVIE INC. | $24.15 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105003457 | CMS |
| ABBVIE INC. | $19.21 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105003459 | CMS |
| Amgen Inc. | $34.92 | 01/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115919221 | CMS |
| Amgen Inc. | $22.15 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117625616 | CMS |
| Amgen Inc. | $13.34 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117625618 | CMS |
| Amgen Inc. | $20.42 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117625620 | CMS |
| Amgen Inc. | $16.64 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117625622 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.94 | 02/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104585464 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.56 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105778050 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.57 | 06/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105875369 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.49 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105202726 | CMS |
| GlaxoSmithKline, LLC. | $18.09 | 01/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116017367 | CMS |
| GlaxoSmithKline, LLC. | $16.15 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116515643 | CMS |
| GlaxoSmithKline, LLC. | $16.25 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116004343 | CMS |
| Janssen Pharmaceuticals, Inc | $24.95 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078100980 | CMS |
| Janssen Pharmaceuticals, Inc | $21.78 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078100944 | CMS |
| Lilly USA, LLC | $20.65 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135201043 | CMS |
| Lilly USA, LLC | $17.85 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135201045 | CMS |
| Novo Nordisk Inc | $14.76 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097560195 | CMS |
| Novo Nordisk Inc | $13.21 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097261294 | CMS |
| Novo Nordisk Inc | $18.15 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097211689 | CMS |
| Organon Llc | $17.38 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136228868 | CMS |
| Organon Llc | $19.55 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136228864 | CMS |
| PFIZER INC. | $16.09 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131343466 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.